Hormonal Predictors of Bone Loss in Elderly Women: A Prospective Study

Oxford University Press (OUP) - Tập 13 Số 7 - Trang 1167-1174 - 1998
Katie Stone1, Douglas C. Bauer1,2, Dennis M. Black1, Peter M. Sklarin3, Kristine E. Ensrud4, S. R. Cummings1,2
1Department of Epidemiology and Biostatistics, University of California, San Francisco, California, U.S.A.
2Division of General Internal Medicine, University of California, San Francisco, California, U.S.A.
3Department of Endocrinology, University of California, San Francisco, California, U.S.A.
4Division of Epidemiology, School of Public Health, University of Minnesota, Minneapolis, Minnesota, U.S.A.

Tóm tắt

Abstract To test the hypotheses that baseline concentrations of sex steroids, sex hormone binding globulin (SHBG), and calciotropic hormones predict rates of bone loss in elderly women, sera were stored at −190°C, and calcaneal bone mineral density (BMD) was measured in 9704 community-dwelling white women aged 65 and over (1986–1988). Hip BMD was measured 2 years later (1990). Repeat measurements of calcaneal and hip BMD were obtained in 1993–1994, after 5.7 and 3.5 years of follow-up, respectively. In 1994, sera were assayed for circulating hormone levels in random subcohorts of 231 and 218 women who did not report current use of hormone replacement therapy at baseline. Lower levels of endogenous estrogens and higher SHBG concentrations were associated with more rapid subsequent bone loss from both the calcaneus and hip. After adjusting for age and weight, women with high SHBG levels (highest quartile ≥ 2.3 μg/dl) experienced an average of 2.2% (95% confidence interval = 1.6%, 2.9%) calcaneal bone loss per year compared with 1.2% (0.7%, 1.2%) among women with low SHBG concentrations (lowest quartile < 1.1 μg/dl; p < 0.01). This association was independent of concentrations of other sex hormones. Women with estradiol levels ≥ 10 pg/ml averaged only 0.1% (−0.7%, 0.5%) annual hip bone loss while women with levels below 5 pg/ml averaged 0.8% (0.3, 1.2) hip bone loss per year. Lower 25-hydroxyvitamin D levels were associated with increased hip but not calcaneal bone loss. Levels of parathyroid hormone, 1,25-dihydroxyvitamin D, and calcium were not significantly associated with bone loss from the calcaneus or hip.

Từ khóa


Tài liệu tham khảo

Riggs, 1986, Involutional osteoporosis, N Engl J Med, 314, 1676, 10.1056/NEJM198606263142605

Gallagher, 1979, Intestinal calcium absorption and serum vitamin D metabolites in normal subjects and osteoporotic patients: Effect of age and dietary calcium, J Clin Invest, 64, 729, 10.1172/JCI109516

Lukert, 1992, Menopausal bone loss is partially regulated by dietary intake of vitamin D, Calcif Tissue Int, 51, 173, 10.1007/BF00334543

Lukert, 1987, Influence of nutritional factors on calcium-regulating hormones and bone loss, Calcif Tissue Int, 40, 119, 10.1007/BF02555695

Flicker, 1992, The effect of aging on intact PTH and bone density in women, J Am Geriatr Soc, 40, 1135, 10.1111/j.1532-5415.1992.tb01803.x

Villareal, 1991, Subclinical vitamin D deficiency in postmenopausal women with low vertebral bone mass, J Clin Endocrinol Metab, 72, 628, 10.1210/jcem-72-3-628

Sowers, 1990, The relationship of 1,25-dihydroxyvitamin D and radial bone mass, Bone Miner, 10, 139, 10.1016/0169-6009(90)90089-X

Tsai, 1987, Effect of aging on vitamin D stores and bone density in women, Calcif Tissue Int, 40, 241, 10.1007/BF02555255

Riggs, 1973, Parathyroid function in primary osteoporosis, J Clin Invest, 52, 181, 10.1172/JCI107162

Punonnen, 1986, Vitamin D deficiency in women with femoral neck fracture, Maturitas, 8, 291, 10.1016/0378-5122(86)90037-X

Riis, 1986, The role of serum concentrations of sex steroids and bone turnover in the development and occurrence of postmenopausal osteoporosis, Calcif Tissue Int, 38, 318, 10.1007/BF02555743

Slemeda, 1987, Sex steroids and bone mass: A study of changes about the time of menopause, J Clin Invest, 80, 1261, 10.1172/JCI113201

Meema, 1975, Preventive effect of estrogen on postmenopausal bone loss, Arch Intern Med, 135, 1436, 10.1001/archinte.1975.00330110026004

Lindsay, 1976, Long-term prevention of postmenopausal osteoporosis of oestrogen, Lancet, 1, 1038, 10.1016/S0140-6736(76)92217-0

Weiss, 1980, Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen, N Engl J Med, 303, 1195, 10.1056/NEJM198011203032102

Slemenda, 1996, 2996 Sex steroids, bone mass, and bone loss, J Clin Invest, 97, 14, 10.1172/JCI118382

Cauley, 1986, The relationship of endogenous estrogen to bone density and bone area in normal postmenopausal women, Am J Epidemiol, 124, 752, 10.1093/oxfordjournals.aje.a114451

Brody, 1987, Serum sex hormone binding globulin (SHBG), testosterone/SHBG index, endometrial pathology and bone mineral density in postmenopausal women, Acta Obstet Gynecol Scand, 66, 357, 10.3109/00016348709103653

Deutsch, 1987, The correlation of serum estrogens and androgens with bond density in the late postmenopause, Int J Gynecol Obstet, 25, 217, 10.1016/0020-7292(87)90238-4

Wild, 1987, Adrenal androgens, sex-hormone binding globulin, and bone density in osteoporotic menopausal women: Is there a relationship?, Maturatis, 9, 55, 10.1016/0378-5122(87)90052-1

Davidson, 1982, Total and free estrogens and androgens in postmenopausal women with hip fractures, J Clin Endocrinol Metab, 54, 115, 10.1210/jcem-54-1-115

Van Hemert, 1989, Sex hormone binding globulin in postmenopausal women: A predictor of osteoporosis superior to endogenous estrogens, Clin Endocrinol, 31, 499, 10.1111/j.1365-2265.1989.tb01274.x

Cummings, 1990, Appendicular bone density and age predict hip fracture in women: The study of osteoporotic fractures, J Am Med Assoc, 263, 665, 10.1001/jama.1990.03440050059033

Steiger, 1992, Age-related decrements in bone mineral density in women over 65, J Bone Miner Res, 7, 625, 10.1002/jbmr.5650070606

Johnston, 1994, Peak bone mass, bone loss and risk of fracture, Osteoporos Int, S43, 10.1007/BF01623435

Martinez, 1994, Relations between calcidiol serum levels and bone mineral desity in postmenopausal women with low bone density, Calcif Tissue Int, 55, 253, 10.1007/BF00310401

Nguyen, 1997, Sources of variability in bone mineral density measurements: Implications for study design and analysis of bone loss, J Bone Miner Res, 12, 124, 10.1359/jbmr.1997.12.1.124